ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Cullgen Inc
A Senior Manager, Corporate Communications leads the company's external messaging strategy, manages investor relations and digital presence, and collaborates with scientific teams to translate complex biotechnology data into engaging content for conferences and press.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2018
Cullgen is a biopharmaceutical company focused on developing targeted protein degraders and Degrader-Antibody Conjugates (DACs) for the treatment of cancer, pain, and inflammatory diseases. The company's platform specializes in drugging previously 'undruggable' targets through protein degradation. Cullgen was acquired by Gyre Therapeutics in 2026 to form a fully integrated U.S.- and China-based biopharmaceutical company.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cullgen Inc.
Cullgen Inc didn’t post a salary, so this is our estimate from similar listings.
3% below the average for this role
Corporate Communications Manager (Banking)
hkjobc
Senior Communications Manager United States Washington Redmond
Microsoft
Senior Director, Investor Relations and Corporate Communications
Ironwood Pharmaceuticals
Manager/Senior Manager, Investor Relations & Corporate Communications
Avalyn Pharma
PR & Corporate Communications
Bold Magazine
Senior Director, Investor Relations and Corporate Communications
Lyell Immunopharma